Precigen Inc (NASDAQ: PGEN) kicked off on Monday, down -8.94% from the previous trading day, before settling in for the closing price of $1.17. Over the past 52 weeks, PGEN has traded in a range of $0.65-$1.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -15.17%. While this was happening, its average annual earnings per share was recorded -20.51%. With a float of $163.53 million, this company’s outstanding shares have now reached $292.87 million.
Let’s determine the extent of company efficiency that accounts for 202 employees. In terms of profitability, gross margin is -63.15%, operating margin of -3277.95%, and the pretax margin is -3573.1%.
Precigen Inc (PGEN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Precigen Inc is 44.16%, while institutional ownership is 26.04%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.51% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Take a look at Precigen Inc’s (PGEN) current performance indicators. Last quarter, stock had a quick ratio of 1.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 79.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Looking closely at Precigen Inc (NASDAQ: PGEN), its last 5-days average volume was 2.35 million, which is a drop from its year-to-date volume of 2.91 million. As of the previous 9 days, the stock’s Stochastic %D was 57.04%. Additionally, its Average True Range was 0.13.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 51.77%, which indicates a significant increase from 49.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.94% in the past 14 days, which was higher than the 83.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8814, while its 200-day Moving Average is $1.1899. However, in the short run, Precigen Inc’s stock first resistance to watch stands at $1.1367. Second resistance stands at $1.2033. The third major resistance level sits at $1.2467. If the price goes on to break the first support level at $1.0267, it is likely to go to the next support level at $0.9833. Now, if the price goes above the second support level, the third support stands at $0.9167.
Precigen Inc (NASDAQ: PGEN) Key Stats
The company with the Market Capitalisation of 313.37 million has total of 292,869K Shares Outstanding. Its annual sales at the moment are 6,230 K in contrast with the sum of -95,900 K annual income. Company’s last quarter sales were recorded 950 K and last quarter income was -23,980 K.
